Trilogy Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.05M Sell
27,547
-5,700
-17% -$632K 0.15% 100
2025
Q1
$3.73M Sell
33,247
-4,060
-11% -$455K 0.2% 77
2024
Q4
$3.45M Sell
37,307
-3,765
-9% -$348K 0.18% 87
2024
Q3
$3.44M Sell
41,072
-235
-0.6% -$19.7K 0.17% 92
2024
Q2
$2.83M Buy
41,307
+3,191
+8% +$219K 0.15% 105
2024
Q1
$2.79M Buy
38,116
+33,202
+676% +$2.43M 0.16% 112
2023
Q4
$398K Sell
4,914
-458
-9% -$37.1K 0.02% 190
2023
Q3
$403K Sell
5,372
-419
-7% -$31.4K 0.03% 176
2023
Q2
$467K Buy
5,791
+742
+15% +$59.8K 0.03% 176
2023
Q1
$419K Sell
5,049
-23,304
-82% -$1.93M 0.03% 166
2022
Q4
$2.43M Sell
28,353
-2,602
-8% -$223K 0.17% 78
2022
Q3
$1.91M Buy
30,955
+3,632
+13% +$224K 0.17% 62
2022
Q2
$1.69M Buy
27,323
+6,079
+29% +$376K 0.15% 61
2022
Q1
$1.26M Buy
21,244
+4,284
+25% +$255K 0.09% 95
2021
Q4
$1.23M Buy
16,960
+757
+5% +$54.9K 0.09% 81
2021
Q3
$1.13M Buy
16,203
+19
+0.1% +$1.33K 0.09% 76
2021
Q2
$1.1M Buy
16,184
+6,318
+64% +$430K 0.08% 78
2021
Q1
$638K Buy
9,866
+741
+8% +$47.9K 0.05% 116
2020
Q4
$532K Buy
9,125
+46
+0.5% +$2.68K 0.04% 113
2020
Q3
$574K Sell
9,079
-360
-4% -$22.8K 0.05% 91
2020
Q2
$737K Buy
9,439
+1,473
+18% +$115K 0.07% 71
2020
Q1
$637K Buy
+7,966
New +$637K 0.07% 67
2019
Q1
Sell
-3,903
Closed -$244K 135
2018
Q4
$244K Sell
3,903
-3,427
-47% -$214K 0.03% 113
2018
Q3
$566K Sell
7,330
-844
-10% -$65.2K 0.07% 90
2018
Q2
$579K Sell
8,174
-468
-5% -$33.2K 0.08% 74
2018
Q1
$652K Buy
+8,642
New +$652K 0.09% 69